ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Update

ViaDerma, Inc. (OTCMKTS:VDRM) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,800 shares, a decrease of 92.7% from the February 29th total of 65,800 shares. Based on an average daily trading volume, of 2,553,200 shares, the short-interest ratio is presently 0.0 days.

ViaDerma Trading Down 3.1 %

OTCMKTS:VDRM traded down 0.00 during trading hours on Friday, reaching 0.01. 900,300 shares of the stock were exchanged, compared to its average volume of 1,938,533. ViaDerma has a twelve month low of 0.01 and a twelve month high of 0.03. The firm has a 50 day moving average of 0.01 and a 200 day moving average of 0.01.

About ViaDerma

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.